skip to primary navigationskip to content

Wellcome - MRC Cambridge Stem Cell Institute

Department A-Z

New Building 2019

Our new home at the Cambridge Biomedical Campus is set to be finished in Spring 2019 and will mean all 29 research groups will be coming together in one building

Read more

For the public

Films, podcasts, games and events...challenge what you think you know about stem cells and discover how our Public Engagement team are working across the field

Read more

Upcoming events

Guest Seminar: Alessandro Bertero

Feb 27, 2019

Lecture Theatre 2, Clinical School Building

International Seminar: Glenn Begley

Mar 13, 2019

William Harvey Lecture Theatre, Clinical School Cambridge Biomedical Campus

Institute Retreat 2019

Mar 14, 2019

Tattershalls, Newmarket, CB8 9AY

Cambridge Science Festival: what a nerve!

Mar 17, 2019

Cambridge Union Society, 9A Bridge Street, CB2 1UB

Cambridge Science Festival: immunology, the future of medicine?

Mar 19, 2019

Mill Lane Lecture Rooms , 8 Mill Lane, CB2 1RW

Upcoming events

The Cambridge Stem Cell Institute is a world-leading centre for stem cell research.

Our mission: to transform human health through a deep understanding of stem cell biology.


Sign up to our newsletter to stay up-to-date with news and events from the Cambridge stem cell community.

RSS Feed Latest news

Establishing the Molecular Blueprint of Early Embryo Development

Feb 20, 2019

A pioneering group of biologists, physicists and mathematical modellers in Cambridge have studied the genetic activity of over 100,000 embryonic cells to establish the molecular blueprint of mouse early embryo development.

Stem Cell Research Hits the Road

Feb 04, 2019

Two PhD students from the Wellcome – MRC Cambridge Stem Cell Institute are embarking on a 6000km journey in a customised Renault 4L to support children and schools in Morocco, and to raise awareness of stem cell research at a global scale.

From eye drops to potential leukaemia treatment

Dec 19, 2018

An active ingredient in eye drops that were being developed for the treatment of a form of eye disease has shown promise for treating an aggressive form of blood cancer.

View all news